SILK - Wutah pendapatan taun lumaku Silk Road Medical Inc

Silk Road Medical, Inc. (SILK) leads the way in minimally invasive treatment of carotid artery stenosis, striving to become the standard of care. The relative year-over-year revenue growth rate (12 months) confirms this trend, where 34.60 shows the current value of the metric. This momentum is driven by the number of trained physicians and the market reach of stroke prevention, while the $1.16 billion acquisition by a tech giant ensures the complete preservation of the customer base.
silkroadmed.com (SILK) - rincian metrik lan laporan keuangan

The long-term reliability of Silk Road Medical (SILK) depends on its ability to sustain medtech expansion while partially outsourcing production and logistics. The rolling year-over-year sales growth trajectory measures the average daily revenue dynamics over the last twelve months, allowing investors to distinguish organic demand growth from temporary fluctuations and confirm the sustainability of the business operating model.